A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
There is evidence to support the view that glutamate hyperactivity might be relevant to the neurobiology of depersonalization. We tested the efficacy of lamotrigine, which reduces glutamate release, as a treatment for patients with depersonalization disorder. A double-blind, placebo-controlled, cross-over design was used to evaluate 12 weeks of treatment of lamotrigine. Subjects comprised nine patients with DSM-IV depersonalization disorder. Changes on the Cambridge Depersonalization Scale and the Present State Examination depersonalization/derealization items were compared across the two cross-over periods. Lamotrigine was not significantly superior to placebo. None of the nine patients was deemed a responder to the lamotrigine arm of the cross-over. Lamotrigine does not seem to be useful as a sole medication in the treatment of depersonalization disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, lamotrigine did not perform better than placebo to reduce dissociative symptoms in a RCT for depersonalization derealization disorder [136].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [136]
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Development, reliability, and validity of a dissociation scale
BERNSTEIN, E. M., & PUTNAM, F. W. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198612000-00004 · Cited by 3,793
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Self-citationDiagnostic and Statistical Manual of Mental Disorder
Ellsworth, P. D. (1980) · The American Journal of Occupational Therapy · doi:10.5014/ajot.34.12.819a · Cited by 1,700
The two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
Malhotra, A. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00137-3 · Cited by 680
The Cambridge Depersonalisation Scale: a new instrument for the measurement of depersonalisation
Sierra, M., & Berrios, G. E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00100-1 · Cited by 467
Self-citationAnand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426
Self-citationGlutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.
Chambers, R. A., Bremner, J. D., Moghaddam, B., Southwick, S. M., Charney, D. S., & Krystal, J. H. (1999) · PubMed · Cited by 140
Self-citationLamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats
Southam, E., Kirkby, D. L., Higgins, G. A., & Hagan, R. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00580-9 · Cited by 129
Research works printed but not linked: 5
- Chambers A C, 1999, Semin Clin Neuropsychiatry, 4, 274
- Dursun S M, 2001, J Psychiatry Neurosci, 26, 168
- Hollander E, 1990, J Clin Psychopharmacol, 3, 200
- 10.1002/(SICI)1098-2396(199611)24:3<248::AID-SYN7>3.0.CO;2-E · doi:10.1002/(sici)1098-2396(199611)24:3<248::aid-syn7>3.0.co;2-e
- Wing J K, 1974, The description and classification of psychiatric symptoms: an instruction manual for the PSE and CATEGO Program
Cited by
Depersonalisation Disorder: A Contemporary Overview
Simeon, D. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00002 · Cited by 198
Tritt, K., Nickel, C., Lahmann, C., Leiberich, P. K., Rother, W. K., Loew, T. H., & Nickel, M. K. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051540 · Cited by 189
Understanding and treating depersonalisation disorder
Medford, N., Sierra, M., Baker, D., & David, A. S. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.2.92 · Cited by 93
Self-citationComplex Trauma in Adolescents and Adults
Briere, J., & Scott, C. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.004 · Cited by 114
Emotional memory in depersonalization disorder: a functional MRI study.
Medford, N., Brierley, B., Brammer, M., Bullmore, E. T., David, A. S., & Phillips, M. L. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.05.007 · Cited by 84
Self-citation
Metadata
- Authors
- Sierra, M., Phillips, M. L., Ivin, G., Krystal, J., & David, A. S.
- Affiliations
- University of London (GB)
- Maudsley Hospital (GB)
- Yale University (US)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2003-01
- Volume
- 17
- Issue
- 1
- Pages
- 103-105
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2134541433
- Cited by
- 73
- References
- 21
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 6 · 2012: 5
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- lamotrigine, depersonalization disorder, depersonalization, derealization, glutamate release, antiepileptic drugs, pharmacotherapy, Present State Examination
- MeSH terms
- Lamotrigine, Adult, Analysis of Variance, Antidepressive Agents, Depersonalization, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Interview, Psychological, Male, Pilot Projects, Triazines, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. https://app.cochat.ai/papers/10.1177/0269881103017001712
- The paper
- Sierra, M., Phillips, M. L., Ivin, G., Krystal, J., & David, A. S. (2003). A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology. https://doi.org/10.1177/0269881103017001712
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.